Monica Fonseca-Aten
Overview
Explore the profile of Monica Fonseca-Aten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Michaels M, Fonseca-Aten M, Green M, Charsha-May D, Friedman B, Seikaly M, et al.
Pediatr Transplant
. 2008 Sep;
13(4):451-6.
PMID: 18785906
RSV can cause respiratory illness after SOT, yet preventive recommendations are lacking for this population. To ascertain current preventive practices against RSV disease in pediatric SOT candidates and recipients, a...
2.
Fonseca-Aten M, Okada P, Bowlware K, Chavez-Bueno S, Mejias A, Rios A, et al.
Ann Allergy Asthma Immunol
. 2006 Oct;
97(4):457-63.
PMID: 17069099
Background: Clarithromycin is postulated to possess immunomodulatory properties in addition to its antimicrobial activity. Objective: To evaluate the effect of clarithromycin on serum and nasopharyngeal cytokine and chemokine concentrations in...
3.
Fonseca-Aten M, Rios A, Mejias A, Chavez-Bueno S, Katz K, Gomez A, et al.
Int J Antimicrob Agents
. 2006 Aug;
28(3):253-8.
PMID: 16891098
Mycoplasma pneumoniae infection has been associated with chronic lung disease. Treatment of chronic pulmonary mycoplasmosis has not been well investigated. BALB/c mice were intranasally inoculated once with M. pneumoniae or...
4.
Fonseca-Aten M, Michaels M
Semin Pediatr Surg
. 2006 Jul;
15(3):153-61.
PMID: 16818136
Despite the progress made in graft and patient survival in recent years, infectious complications remain a major source of morbidity and mortality in pediatric solid organ transplant recipients. The risk...
5.
Fonseca-Aten M, Salvatore C, Mejias A, Rios A, Chavez-Bueno S, Katz K, et al.
Antimicrob Agents Chemother
. 2005 Sep;
49(10):4128-36.
PMID: 16189089
Mycoplasma pneumoniae is a major cause of community-acquired pneumonia. We evaluated the efficacy of LBM415, a novel peptide deformylase inhibitor antimicrobial agent, for the treatment of M. pneumoniae pneumonia in...
6.
Rios A, Fonseca-Aten M, Mejias A, Chavez-Bueno S, Katz K, Gomez A, et al.
Antimicrob Agents Chemother
. 2005 Aug;
49(9):3970-3.
PMID: 16127085
We evaluated the efficacy of azithromycin therapy given as a single high dose or divided over 5 days for the treatment of mild experimental Mycoplasma pneumoniae pneumonia. Although both azithromycin...
7.
Chavez-Bueno S, Mejias A, Gomez A, Olsen K, Rios A, Fonseca-Aten M, et al.
Virol J
. 2005 May;
2:46.
PMID: 15916706
Background: Respiratory syncytial virus (RSV) is the leading respiratory viral pathogen in young children worldwide. RSV disease is associated with acute airway obstruction (AO), long-term airway hyperresponsiveness (AHR), and chronic...
8.
Fonseca-Aten M, Messina A, Jafri H, Sanchez P
Pediatrics
. 2005 Mar;
115(3):804-9.
PMID: 15741392
Cutaneous herpes simplex virus type 2 (HSV-2) infection was recognized at 19 days of age in a 1415-g female infant born at 31 weeks of gestation. Cerebrospinal fluid (CSF) HSV...
9.
Fonseca-Aten M, Rios A, Mejias A, Chavez-Bueno S, Katz K, Gomez A, et al.
Am J Respir Cell Mol Biol
. 2005 Jan;
32(3):201-10.
PMID: 15626776
Respiratory tract infections result in wheezing in a subset of patients. Mycoplasma pneumoniae is a common etiologic agent of acute respiratory infection in children and adults that has been associated...
10.
Rios A, Mejias A, Chavez-Bueno S, Fonseca-Aten M, Katz K, Hatfield J, et al.
Antimicrob Agents Chemother
. 2004 Jul;
48(8):2897-904.
PMID: 15273098
Mycoplasma pneumoniae is a major etiologic agent of acute lower respiratory infections. We evaluated the antimicrobial and immunologic effects of cethromycin (ABT-773), a ketolide antibiotic, for the treatment of M....